PCVX
Vaxcyte, Inc. Common Stock
Nasdaq · usd
Vaxcyte, Inc. Common Stock (PCVX) trades at $59.57 (-1.43%) as of 2:24:11 PM EDT on Oct 26, 2026, +6.00% over the past month. Market cap is $9.51B, with 11.4 days to cover in short interest.
Stock performance
How Vaxcyte, Inc. Common Stock (PCVX) stock has performed from one day to one year, with its 52-week range.
- 1D
- -1.41%
- 1W
- -6.44%
- 1M
- +6.00%
- YTD
- +29.13%
- 1Y
- +33.68%
- 52-wk range
- $39.87 – $90.75
Key statistics
Today's trading snapshot for PCVX: day range, open, previous close, volume and market cap.
- Day range
- $59.39 – $61.50
- Open
- $60.68
- Prev close
- $60.43
- Volume
- 759.84K
- Market cap
- $9.51B
- Shares out
- 148.81M
Valuation and profitability ratios: P/E, P/S, ROE
Valuation and profitability ratios for Vaxcyte, Inc. Common Stock: P/E, P/S, P/B, ROE and more.
- P/E
- —
- P/S
- —
- P/B
- 3.45
- P/FCF
- —
- ROE
- -38.6%
- ROA
- -33.9%
- Debt/Equity
- 0.00
- Div yield
- 0.00%
As of Oct 23, 2026
8-K filings
Material corporate events Vaxcyte, Inc. Common Stock has disclosed to the SEC on Form 8-K.
- Underwriting agreementOct 9, 2026
On October 6, 2026, Vaxcyte entered into an underwriting agreement... relating to the issuance and sale... of 7,412,500 shares of Common Stock... and pre-funded warrants to purchase 400,000 shares of its Common Stock.
- Investor presentationOct 5, 2026
On October 5, 2026, the Company also made available the slide presentation attached as Exhibit 99.2 to this Current Report on Form 8-K.
- Executive officer appointmentSep 3, 2026
On August 31, 2026, Vaxcyte, Inc. (the "Company") appointed David McAvoy as the Company's Chief Legal Officer, Chief Compliance Officer, and Corporate Secretary.
- Director appointmentJul 15, 2026
Concurrently, upon recommendation of the Nominating and Corporate Governance Committee of the Board, the Board appointed John Markels to the Board as a Class II director, effective as of July 16, 2026. Dr. Markels' term will expire at the Company's annual meeting of stockholders in 2028. The Board also appointed Dr. Markels to serve as a member of the Audit Committee and Compensation Committee of the Board.
- Director departureJun 23, 2026
On June 17, 2026, Jacks Lee notified the Board of Directors (the "Board") of Vaxcyte, Inc. of his retirement from the Board, effective as of June 17, 2026. Mr. Lee's retirement was not the result of any disagreement or dispute with the Company.
PCVX short interest
How heavily PCVX is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 11.4
- Short interest
- 17.29M
- Avg volume
- 1.52M
As of · reported to FINRA twice monthly.
PCVX news
The latest news and headlines about Vaxcyte, Inc. Common Stock (PCVX).
- Wall Street Analysts Think Vaxcyte (PCVX) Could Surge 75.6%: Read This Before Placing a BetpositiveZacks Investment Research· Oct 14, 2026
- Vaxcyte Announces Pricing of Concurrent Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior NotespositiveGlobeNewswire Inc.· Oct 6, 2026
- Novavax (NVAX) Surges 20.1%: Is This an Indication of Further Gains?positiveZacks Investment Research· Oct 6, 2026
- Stock Market Today, Oct. 5: Tech Momentum Lifts Nasdaq as Treasury Yields SurgepositiveThe Motley Fool· Oct 5, 2026
- The Zacks Analyst Blog Highlights Kodiak Sciences, Celldex Therapeutics, Rapport Therapeutics and VaxcytenegativeZacks Investment Research· Sep 23, 2026
Frequently asked questions
What is the Vaxcyte, Inc. Common Stock (PCVX) stock price today?
Vaxcyte, Inc. Common Stock (PCVX) is trading at $59.57 (-1.43% on the day) as of 2:24:11 PM EDT on Oct 26, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Vaxcyte, Inc. Common Stock?
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine…
What is the short interest in PCVX?
As of Sep 30, 2026, PCVX has 17.29M shares short and 11.4 days to cover.
What exchange is PCVX listed on?
Vaxcyte, Inc. Common Stock (PCVX) trades on Nasdaq in USD, in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry.
Build with AI
Build an analysis of PCVX with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a PCVX analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.